Literature DB >> 7582508

The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.

S M Poucher1, J R Keddie, P Singh, S M Stoggall, P W Caulkett, G Jones, M G Coll.   

Abstract

1. This paper describes the in vitro pharmacology of ZM 241385 (4-(2-[7-amino-2-(2-furyl) [1,2,4]-triazolo[2,3-a][1,3,5]triazin- 5-yl amino]ethyl) phenol), a novel non-xanthine adenosine receptor antagonist with selectivity for the A2a receptor subtype. 2. ZM 241385 had high affinity for A2a receptors. In rat phaeochromocytoma cell membranes, ZM 241385 displaced binding of tritiated 5'-N-ethylcarboxamidoadenosine (NECA) with a pIC50 of 9.52, (95% confidence limits, c.l., 9.02-10.02). In guinea-pig isolated Langendorff hearts, ZM 241385 antagonized vasodilatation of the coronary bed produced by 2-chloroadenosine (2-CADO) and 2-[p-(2-carboxyethyl) phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680) with pA2 values of 8.57 (c.l., 8.45-8.68) and 9.02 (c.l., 8.79-9.24) respectively. 3. ZM 241385 had low potency at A2b receptors and antagonized the relaxant effects of adenosine in the guinea-pig aorta with a pA2 of 7.06, (c.l., 6.92-7.19). 4. ZM 241385 had a low affinity at A1 receptors. In rat cerebral cortex membranes it displaced tritiated R-phenylisopropyladenosine (R-PIA) with a pIC50 of 5.69 (c.l., 5.57-5.81). ZM 241385 antagonized the bradycardic action of 2-CADO in guinea-pig atria with a pA2 of 5.95 (c.l., 5.72-6.18). 5. ZM 241385 had low affinity for A3 receptors. At cloned rat A3 receptors expressed in chinese hamster ovary cells, it displaced iodinated aminobenzyl-5'-N-methylcarboxamido adenosine (AB-MECA) with a pIC50 of 3.82 (c.l., 3.67-4.06). 6. ZM 241385 had no significant additional pharmacological effects on the isolated tissues used in these studies at concentrations three orders of magnitude greater than those which block A2a receptors. At 10 microM it displayed only minor inhibition of the bradycardic effects in guinea-pig atria to some concentrations of carbachol. At 10 microM, ZM 241385 had a small inhibitory effect on relaxant effects of isoprenaline in guinea-pig aortae but no effect on sodium nitrite-induced relaxation. ZM 241385(100 microM) was without effect on phenylephrine-induced tone in guinea-pig aortae.7. ZM 241385 (10 microM) had no inhibitory effect on rat hepatocyte phosphodiesterase types I, II, III and IV but caused a small inhibition of the calcium calmodulin-activated type I enzyme.8. ZM 241385 is the most selective adenosine A2a receptor antagonist yet described and is therefore a useful tool for characterization of responses mediated by A2 adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582508      PMCID: PMC1909020          DOI: 10.1111/j.1476-5381.1995.tb15923.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Relative agonist potencies of C2-substituted analogues of adenosine: evidence for adenosine A2B receptors in the guinea pig aorta.

Authors:  P L Martin
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

2.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain.

Authors:  W J Thompson; M M Appleman
Journal:  Biochemistry       Date:  1971-01-19       Impact factor: 3.162

3.  2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.

Authors:  M Ueeda; R D Thompson; L H Arroyo; R A Olsson
Journal:  J Med Chem       Date:  1991-04       Impact factor: 7.446

4.  L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.

Authors:  P K Moore; A O Oluyomi; R C Babbedge; P Wallace; S L Hart
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

5.  The coexistence of adenosine A1 and A2 receptors in guinea-pig aorta.

Authors:  S M Stoggall; J S Shaw
Journal:  Eur J Pharmacol       Date:  1990-11-13       Impact factor: 4.432

6.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

7.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.

Authors:  I Hide; W L Padgett; K A Jacobson; J W Daly
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

9.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  PD 115,199: an antagonist ligand for adenosine A2 receptors.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; S J Hays
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

View more
  86 in total

1.  Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus.

Authors:  T Shindou; A Mori; H Kase; M Ichimura
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

2.  [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.

Authors:  X Ji; Y C Kim; D G Ahern; J Linden; K A Jacobson
Journal:  Biochem Pharmacol       Date:  2001-03-15       Impact factor: 5.858

3.  Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

4.  Accelerated resequestration of cytosolic calcium and suppression of the pro-inflammatory activities of human neutrophils by CGS 21680 in vitro.

Authors:  R Anderson; S S Visser; G Ramafi; A J Theron
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  A(2A) adenosine receptor mediated potassium channel activation in rat epididymal smooth muscle.

Authors:  J M Haynes
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

6.  Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.

Authors:  X D Ji; K A Jacobson
Journal:  Drug Des Discov       Date:  1999-11

7.  Activation of Trk neurotrophin receptors in the absence of neurotrophins.

Authors:  F S Lee; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

8.  Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Authors:  G W Sullivan; J M Rieger; W M Scheld; T L Macdonald; J Linden
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

9.  Enhanced adenosine A(2B) mediated coronary response in reserpinised rat heart.

Authors:  Roselyn B Rose'Meyer; Glenn J Harrison; John P Headrick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

10.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.